Astrazeneca Phar — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Astrazeneca Phar holds 75.00% of the company. At a market capitalisation of ₹15.86k cr, that holding is worth ₹11.90k cr.

Promoter stake

75.00%

Value of holding

₹11.90k cr

Market cap

₹15.86k cr

Stake change

0.00%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
75.00%—
Q4-2021
75.00%—
Q1-2022
75.00%—
Q2-2022
75.00%—
Q3-2022
75.00%—
Q4-2022
75.00%—
Q1-2023
75.00%—
Q2-2023
75.00%—
Q3-2023
75.00%—
Q4-2023
75.00%—
Q1-2024
75.00%—
Q2-2024
75.00%—
Q3-2024
75.00%—
Q4-2024
75.00%—
Q1-2025
75.00%—
Q2-2025
75.00%—
Q3-2025
75.00%—
Q4-2025
75.00%—
Q1-2026
75.00%—
Q2-2026
75.00%—
Q3-2026
75.00%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Astrazeneca Phar's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.